Importer of Controlled Substances Registration, 28011-28012 [2018-12884]
Download as PDF
<![CDATA[
28011
Federal Register / Vol. 83, No. 116 / Friday, June 15, 2018 / Notices
identifying information—might be made
publicly available at any time. While
you can ask us in your comment to
withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so. Comments and materials we
receive will be available for public
inspection by appointment, during
normal business hours, at the Service’s
Pacific Islands Fish and Wildlife Office
(see FOR FURTHER INFORMATION CONTACT
section).
Authority
We provide this notice in accordance
with the requirements of section 10 of
the ESA (16 U.S.C. 1531 et seq.).
Theresa E. Rabot,
Deputy Regional Director, Pacific Region, U.S.
Fish and Wildlife Service.
[FR Doc. 2018–12889 Filed 6–14–18; 8:45 am]
BILLING CODE 4333–15–P
INTERNATIONAL TRADE
COMMISSION
FOR FURTHER INFORMATION CONTACT:
Amelia Shister (202–205–2047), Office
of Investigations, U.S. International
Trade Commission, 500 E Street SW,
Washington, DC 20436. Hearingimpaired individuals are advised that
information on this matter can be
obtained by contacting the
Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server (https://
www.usitc.gov).
Authority: This investigation is being
terminated under authority of title VII of the
Tariff Act of 1930 and pursuant to section
207.40(a) of the Commission’s Rules of
Practice and Procedure (19 CFR 207.40(a)).
This notice is published pursuant to section
201.10 of the Commission’s rules (19 CFR
201.10).
By order of the Commission.
Issued: June 12, 2018.
Lisa Barton,
Secretary to the Commission.
[Investigation No. 701–TA–581 (Final)]
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote on Inv. Nos. 701–TA–588 and
731–TA–1392–1393 (Final)
(Polytetrafluoroethylene (‘‘PTFE’’) Resin
from China and India). The Commission
is currently scheduled to complete and
file its determinations and views of the
Commission by July 6, 2018.
5. Outstanding action jackets: None.
In accordance with Commission
policy, subject matter listed above, not
disposed of at the scheduled meeting,
may be carried over to the agenda of the
following meeting.
By order of the Commission.
Issued: June 12, 2018.
William Bishop,
Supervisory Hearings and Information
Officer.
[FR Doc. 2018–12973 Filed 6–13–18; 11:15 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Citric Acid and Certain Citrate Salts
From Thailand; Termination of
Investigation
[FR Doc. 2018–12905 Filed 6–14–18; 8:45 am]
BILLING CODE 7020–02–P
Importer of Controlled Substances
Registration
United States International
Trade Commission.
ACTION: Notice.
INTERNATIONAL TRADE
COMMISSION
ACTION:
AGENCY:
On June 5, 2018, the
Department of Commerce published
notice in the Federal Register of a
negative final determination of
subsidies in connection with the subject
investigation concerning citric acid and
certain citrate salts from Thailand (83
FR 26004). Accordingly, the
countervailing duty investigation
concerning citric acid and certain citrate
salts from Thailand (Investigation No.
701–TA–581 (Final)) is terminated.
DATES: June 5, 2018.
Registrants listed below have
applied for and been granted
registration by-the Drug Enforcement
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
SUPPLEMENTARY INFORMATION: The
companies listed below applied to be
registered as importers of various basic
classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
SUMMARY:
[USITC SE–18–028]
SUMMARY:
Notice of registration.
Government in the Sunshine Act
Meeting Notice
United
States International Trade Commission.
TIME AND DATE: June 22, 2018 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
AGENCY HOLDING THE MEETING:
FR citation
Sharp Clinical Services, Inc ..................................................................................................................
Fisher Clinical Services, Inc ..................................................................................................................
Wildlife Laboratories Inc ........................................................................................................................
Catalent Pharma Solutions, LLC ..........................................................................................................
Lipomed .................................................................................................................................................
Almac Clinical Services Incorp .............................................................................................................
Clinical Supplies Management Holdings, Inc .......................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
Company
83 FR 13521
83 FR 13519
83 FR 14505
83 FR 14504
83 FR 15627
(ACSI) 83 FR 15634
83 FR 16901
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
VerDate Sep<11>2014
17:11 Jun 14, 2018
Jkt 244001
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
Published
March 29, 2018.
March 29, 2018.
April 4, 2018.
April 4, 2018.
April 11, 2018.
April 11, 2018.
April 17, 2018.
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
E:\FR\FM\15JNN1.SGM
15JNN1
28012
Federal Register / Vol. 83, No. 116 / Friday, June 15, 2018 / Notices
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
granted a registration as an importer for
schedule I or II controlled substances to
the above listed companies.
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018–12884 Filed 6–14–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
sradovich on DSK3GMQ082PROD with NOTICES
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On June 6, 2018, the Department of
Justice filed a Complaint and
concurrently lodged a proposed Consent
Decree to resolve claims by the United
States and the State of West Virginia
against Defendant Felman Production,
LLC for violations of the Clean Air Act,
specifically the National Emission
Standards for Hazardous Air Pollutants
for Ferroalloys Production as codified at
40 CFR part 63, subpart XXX, effective
May 20, 1999, as amended on March 22,
2001, as well as West Virginia’s State
Implementation Plan and Defendant’s
Title V Permit. The Complaint alleges
that Defendant failed to comply with
opacity standards, performance testing
and monitoring requirements, and good
air pollution control practices at its
silicomanganese facility in Letart, West
Virginia. The proposed Consent Decree
addresses the alleged violations by
requiring Defendant to install pollutioncontrol measures, conduct additional
monitoring for pollution, and pay a
$200,000 civil penalty, equal shares of
which are allocated between the United
States and the State of West Virginia.
The publication of this notice opens
a period for public comment on the
Consent Decree. Comments should be
addressed to the Acting Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. Felman
Production, LLC, Civil Action No. 3:18–
cv–01003 (S.D. W. Va.), DOJ number
90–5–2–1–10991. All comments must be
submitted no later than 30 days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
VerDate Sep<11>2014
17:11 Jun 14, 2018
Jkt 244001
To submit
comments:
Send them to:
By mail .........
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
During the public comment period,
the Consent Decree may be examined
and downloaded at this Justice
Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
Consent Decree upon written request
and payment of reproduction costs.
Please mail your request and payment
to: Consent Decree Library, US DOJ—
ENRD, P.O. Box 7611, Washington, DC
20044–7611.
Please enclose a check or money order
for $21.00 (25 cents per page
reproduction cost) payable to the United
States Treasury. For a paper copy
without the exhibits and signature
pages, the cost is $18.50.
Robert Brook,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2018–12862 Filed 6–14–18; 8:45 am]
BILLING CODE 4410–15–P
OFFICE OF MANAGEMENT AND
BUDGET
Cumulative Report of Rescissions
Proposals Pursuant to the
Congressional Budget and
Impoundment Control Act of 1974
Executive Office of the
President, Office of Management and
Budget.
ACTION: Notice of monthly cumulative
report pursuant to the Congressional
Budget and Impoundment Control Act
of 1974.
AGENCY:
Pursuant to the Congressional
Budget and Impoundment Control Act
of 1974, OMB is issuing a cumulative
report from the Director detailing the
status of rescission proposals that were
previously transmitted to the Congress
on May 8, 2018, and amended by the
supplementary message transmitted on
June 5, 2018.
DATES: Release Date: June 8, 2018.
ADDRESSES: The cumulative report is
available on-line on the OMB website at:
https://www.whitehouse.gov/omb/
budget-rescissions-deferrals/.
FOR FURTHER INFORMATION CONTACT:
Jessica Andreasen, 6001 New Executive
Office Building, Washington, DC 20503,
Email address: jandreasen@
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
omb.eop.gov, telephone number: (202)
395–3645. Because of delays in the
receipt of regular mail related to
security screening, respondents are
encouraged to use electronic
communications.
John Mulvaney,
Director.
[FR Doc. 2018–12909 Filed 6–14–18; 8:45 am]
BILLING CODE 3110–01–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
Institute of Museum and Library
Services
Submission for OMB Review,
Comment Request, Proposed
Collection: IMLS Inspire! Grants for
Small Museums (IGSM) Notice of
Funding Opportunity
Institute of Museum and
Library Services, National Foundation
on the Arts and the Humanities.
ACTION: Submission for OMB review,
comment request.
AGENCY:
The Institute of Museum and
Library Services announces the
following information collection has
been submitted to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act. This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. This notice proposes
the clearance of the instructions for the
IMLS Inspire! Grants for Small
Museums (IGSM) Notice of Funding
Opportunity. A copy of the proposed
information collection request can be
obtained by contacting the individual
listed below in the ADDRESSES section of
this notice.
DATES: Comments must be submitted to
the office listed in the CONTACT section
below on or before July 16, 2018.
ADDRESSES: Comments should be sent to
Office of Information and Regulatory
Affairs, Attn.: OMB Desk Officer for
Education, Office of Management and
Budget, Room 10235, Washington, DC
20503, (202) 395–7316.
FOR FURTHER INFORMATION CONTACT: Dr.
Sandra Webb, Director of Grant Policy
and Management, Institute of Museum
and Library Services, 955 L’Enfant Plaza
North SW, Suite 4000, Washington, DC
20024–2135. Dr. Webb can be reached
SUMMARY:
E:\FR\FM\15JNN1.SGM
15JNN1
]]>Agencies
[Federal Register Volume 83, Number 116 (Friday, June 15, 2018)]
[Notices]
[Pages 28011-28012]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12884]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Registrants listed below have applied for and been granted
registration by-the Drug Enforcement Administration (DEA) as importers
of various classes of schedule I or II controlled substances.
SUPPLEMENTARY INFORMATION: The companies listed below applied to be
registered as importers of various basic classes of controlled
substances. Information on previously published notices is listed in
the table below. No comments or objections were submitted and no
requests for hearing were submitted for these notices.
----------------------------------------------------------------------------------------------------------------
Company FR citation Published
----------------------------------------------------------------------------------------------------------------
Sharp Clinical Services, Inc........... 83 FR 13521 March 29, 2018.
Fisher Clinical Services, Inc.......... 83 FR 13519 March 29, 2018.
Wildlife Laboratories Inc.............. 83 FR 14505 April 4, 2018.
Catalent Pharma Solutions, LLC......... 83 FR 14504 April 4, 2018.
Lipomed................................ 83 FR 15627 April 11, 2018.
Almac Clinical Services Incorp......... (ACSI) 83 FR 15634 April 11, 2018.
Clinical Supplies Management Holdings, 83 FR 16901 April 17, 2018.
Inc.
----------------------------------------------------------------------------------------------------------------
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the registration of the listed registrants
to import the applicable basic classes of schedule I or II controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated each company's
maintenance of effective controls against diversion by inspecting and
testing each company's physical security systems, verifying each
company's compliance with state and local laws, and reviewing each
company's background and history.
[[Page 28012]]
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the DEA has granted a registration as
an importer for schedule I or II controlled substances to the above
listed companies.
Dated: June 6, 2018.
John J. Martin,
Assistant Administrator.
[FR Doc. 2018-12884 Filed 6-14-18; 8:45 am]
BILLING CODE 4410-09-P
